Language selection

Search

2013-12-11 - Male - 10 Years old

900043562

Adverse reaction report number 900043562
Latest AER version number 1
Market authorization holder AER number ALL1-2013-08447
Initial received date 2013-12-11
Latest received date 2013-12-30
Age 10 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectOral 1 Year(s)Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral25 Milligram Attention deficit/hyperactivity disorder
PREDNISONEConcomitantUnknown Product used for unknown indication

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Date modified: